Go ahead and look at financials for the company GW pharm- youll notice in their financials they have a section for research and development. Its right above the administrative and professional fees. Then go look at cbis' financials, youll only notice a line for administrative and professional fees- none for research and development. That, with the 87 million dollars in the red is the reason cbis is going down. Please stop with the research and development shenanigans
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.